- Home
- TTWO vs ONC Comparison
TTWO vs ONC Comparison
Compare TTWO & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTWO
- ONC
- Stock Information
- Founded
- TTWO 1993
- ONC 2010
- Country
- TTWO United States
- ONC Switzerland
- Employees
- TTWO N/A
- ONC N/A
- Industry
- TTWO Computer Software: Prepackaged Software
- ONC Biotechnology: Pharmaceutical Preparations
- Sector
- TTWO Technology
- ONC Health Care
- Exchange
- TTWO Nasdaq
- ONC Nasdaq
- Market Cap
- TTWO 45.2B
- ONC 37.3B
- IPO Year
- TTWO 1997
- ONC N/A
- Fundamental
- Price
- TTWO $258.83
- ONC $342.50
- Analyst Decision
- TTWO Strong Buy
- ONC Strong Buy
- Analyst Count
- TTWO 22
- ONC 10
- Target Price
- TTWO $249.27
- ONC $340.70
- AVG Volume (30 Days)
- TTWO 1.8M
- ONC 297.4K
- Earning Date
- TTWO 11-05-2025
- ONC 11-11-2025
- Dividend Yield
- TTWO N/A
- ONC N/A
- EPS Growth
- TTWO N/A
- ONC N/A
- EPS
- TTWO N/A
- ONC N/A
- Revenue
- TTWO $5,799,200,000.00
- ONC $4,562,002,000.00
- Revenue This Year
- TTWO $11.46
- ONC $896.81
- Revenue Next Year
- TTWO $51.98
- ONC N/A
- P/E Ratio
- TTWO N/A
- ONC N/A
- Revenue Growth
- TTWO 7.33
- ONC 47.33
- 52 Week Low
- TTWO $146.76
- ONC $170.99
- 52 Week High
- TTWO $261.47
- ONC $355.30
- Technical
- Relative Strength Index (RSI)
- TTWO 65.30
- ONC 57.00
- Support Level
- TTWO $252.55
- ONC $334.53
- Resistance Level
- TTWO $261.09
- ONC $355.30
- Average True Range (ATR)
- TTWO 5.99
- ONC 7.30
- MACD
- TTWO 0.27
- ONC 0.00
- Stochastic Oscillator
- TTWO 87.51
- ONC 61.75
About TTWO Take-Two Interactive Software Inc.
Take-Two is one of the largest global developers and publishers of video games, with labels including Rockstar, 2K, and Zynga. Grand Theft Auto is the firm's biggest franchise, accounting for about 30% of total sales for the past decade. NBA 2K is the industry's dominant basketball video game, with Take-Two releasing a new version annually. Other notable franchises include Red Dead Redemption, Borderlands, and Civilization. Typically, more than three quarters of the firm's sales are from in-game spending, with the remainder coming from initial game sales. Since acquiring Zynga in 2022, mobile makes up about half of total sales.
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.